RINVOQ Complete

RINVOQ Complete has your back with 1-to-1 support when you need it. You’ll get help finding potential ways to save on your prescription, answers to your health insurance coverage questions, and tips on fitting RINVOQ into your everyday routine.

You could pay $0 a month * for RINVOQ

With the RINVOQ Complete Savings Card, you may pay as little as $0 per prescription.

*For eligible, commercially insured patients only. Please see Terms and Conditions here.

An App designed around you

Stay on track with your RINVOQ treatment plan by setting medication reminders and logging your symptoms to share with your doctor. Eligible patients can even access your RINVOQ Complete Savings Card—all in the palm of your hand.

Download the App now

Search for “RINVOQ Complete” at the App Store ® or Google Play™.

Text APP to 33101 to receive a link to download the RINVOQ Complete App

Message and data rates may apply. Visit SeeRTerms.com and see Terms of Use at abbv.ie/s-use. Text STOP to 33101 to unsubscribe.

See the RINVOQ Complete App in action

1-to-1 support from someone who has your back

Your RINVOQ Complete Nurse Ambassador † can help you understand your condition, explain how to take and store RINVOQ as prescribed by your doctor, and help you start and stay with your prescribed treatment routine.

A RINVOQ Complete Ambassador Resource Specialist † can help experienced RINVOQ patients when getting a new job, new doctor, or when “life happens” so you can stay with your prescribed treatment routine. Reach out at 1.800.2RINVOQ (1.800.274.6867).

An Insurance Specialist can help explain possible savings options and navigate changes in your health insurance coverage.

Chat live with RINVOQ Complete Specialists 24/7 to find answers, anytime.

† Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.

Frequently asked questions about RINVOQ

We know you’ve got this, but you might have a question or two. Take a look below to find some answers. If you have other questions, be sure to talk to your doctor.

It is important to take your medication as prescribed. If you miss a dose, give your doctor a call. He or she can walk you through what to do next.

RINVOQ should be stored in the original bottle between 36°F and 77°F (between 2°C and 25°C) to protect it from moisture.

Keep RINVOQ and all medicines out of the reach of children.

A specialty pharmacy distributes medications for people with serious health conditions requiring complex therapies.

These medications are considered complex because of the way they are administered, their side effects, or the conditions they are used to treat.

As you go through the prescription process, remember: your Ambassador is here to help. Get in touch by calling 1.800.2RINVOQ (1.800.274.6867).

To find how much of your RINVOQ prescription may be covered by Medicare or Medicaid, reach out to one of our Insurance Specialists by calling 1.800.2RINVOQ (1.800.274.6867).

If your pharmacy is unable to process your RINVOQ Complete Savings Card for instant savings, you may still be able to get RINVOQ for as little as $0 a month* by receiving a rebate for the amount you paid for your prescription.

*For eligible, commercially insured patients. Please see Terms and Conditions here.

Connect with your Ambassador or one of our Insurance Specialists to help you navigate the health insurance process.

You may receive a comprehensive summary of health insurance benefits, including out-of-pocket costs for RINVOQ, or information about the health insurance process, including appeals.

To speak with an Insurance Specialist, call 1.800.2RINVOQ (1.800.274.6867).

RINVOQ Complete is here to help you navigate through unpredictable life changes. We encourage you to reach out to your Ambassador or an Insurance Specialist for guidance.

Financial assistance may be available—at no additional cost to you—through AbbVie Patient Access Support. See if you qualify.

Changing to a different plan, or changes within your current plan, can lead to disruptions in coverage if you’re not prepared.

Things to consider:

1. What medical expenses do you anticipate for the upcoming year?
2. Are your current doctors, hospitals, and other medical facilities in the plan’s network?
3. Are there limits on coverage for certain conditions?
4. Are your prescription medications, including RINVOQ, covered?

Once you have answers to these questions, use our Health Insurance Comparison Chart to help you see how each plan stacks up. Then, based on your needs, you can choose the plan that is the best option for you.

Have more questions? Speak with one of our Insurance Specialists today at 1.800.2RINVOQ (1.800.274.6867).

Medicare is a health insurance program, funded by the federal government, which provides health benefits for people 65 and older or younger people with certain disabilities.

For information on Medicare, visit Insurance Explained, where you’ll find an overview of Medicare and additional resources to help deepen your understanding.

Our Insurance Specialists are also here to help. Call 1.800.2RINVOQ (1.800.274.6867).

Medicaid is a health coverage program funded jointly by the federal government and individual states.

It provides medical assistance for:

• Low-income adults
• Pregnant women
• Children
• Elderly adults
• People with disabilities

State Medicaid programs may provide coverage for RINVOQ—depending on where you live.

For more information on Medicaid, visit Insurance Explained.

To find out the specific coverage policy and information for your particular state's Medicaid program, please call 1.800.2RINVOQ (1.800.274.6867).

Get the resources you need, when you need them.

See how to verify your health insurance, find potential savings, and get your RINVOQ prescription.

RINVOQ Complete Savings Card Terms and Conditions

Eligibility: Available to patients with commercial insurance coverage for RINVOQ ® (upadacitinib) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit RINVOQSavingsCard.com or call 1.800.2RINVOQ for additional information. To learn about AbbVie's privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy

USES

RINVOQ is a prescription medicine used to treat:

• Adults with moderate to severe rheumatoid arthritis (RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.
• Adults with active psoriatic arthritis(PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with active ankylosing spondylitis (AS) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation when a TNF blocker medicine has been used, and did not work well or could not be tolerated.
• Adults with moderate to severe ulcerative colitis (UC) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Adults with moderate to severe Crohn’s disease (CD) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.

It is not known if RINVOQ is safe and effective in children with ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, or Crohn's disease.

• Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis [AD]) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended.

It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.

It is not known if RINVOQ LQ is safe and effective in children with atopic dermatitis.

RINVOQ/RINVOQ LQ is a prescription medicine used to treat:

• Children 2 years of age and older with active polyarticular juvenile idiopathic arthritis (pJIA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
• Children 2 to less than 18 years of age with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.

It is not known if RINVOQ/RINVOQ LQ is safe and effective in children under 2 years of age with polyarticular juvenile idiopathic arthritis or psoriatic arthritis.

IMPORTANT SAFETY INFORMATION FOR RINVOQ/RINVOQ LQ (upadacitinib)

What is the most important information I should know about RINVOQ**?

RINVOQ may cause serious side effects, including:

• Serious infections. RINVOQ can lower your ability to fight infections. Serious infections have happened while taking RINVOQ, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider (HCP) should test you for TB before starting RINVOQ and check you closely for signs and symptoms of TB during treatment with RINVOQ. You should not start taking RINVOQ if you have any kind of infection unless your HCP tells you it is okay. If you get a serious infection, your HCP may stop your treatment until your infection is controlled. You may be at higher risk of developing shingles (herpes zoster).
• Increased risk of death in people 50 years and older who have at least 1 heart disease (cardiovascular) risk factor.
• Cancer and immune system problems. RINVOQ may increase your risk of certain cancers. Lymphoma and other cancers, including skin cancers, can happen. Current or past smokers are at higher risk of certain cancers, including lymphoma and lung cancer. Follow your HCP's advice about having your skin checked for skin cancer during treatment with RINVOQ. Limit the amount of time you spend in sunlight. Wear protective clothing when you are in the sun and use sunscreen.
• Increased risk of major cardiovascular (CV) events, such as heart attack, stroke, or death, in people 50 years and older who have at least 1 heart disease (CV) risk factor, especially if you are a current or past smoker.
• Blood clots. Blood clots in the veins of the legs or lungs and arteries can happen with RINVOQ. This may be life-threatening and cause death. Blood clots in the veins of the legs and lungs have happened more often in people who are 50 years and older and with at least 1 heart disease (CV) risk factor.
• Allergic reactions. Symptoms such as rash (hives), trouble breathing, feeling faint or dizzy, or swelling of your lips, tongue, or throat, that may mean you are having an allergic reaction have been seen in people taking RINVOQ. Some of these reactions were serious. If any of these symptoms occur during treatment with RINVOQ, stop taking RINVOQ and get emergency medical help right away.
• Tears in the stomach or intestines. This happens most often in people who take nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids. Get medical help right away if you get stomach-area pain, fever, chills, nausea, or vomiting.
• Changes in certain laboratory tests. Your HCP should do blood tests before you start taking RINVOQ and while you take it. Your HCP may stop your RINVOQ treatment for a period of time if needed because of changes in these blood test results.

Do not take RINVOQ if you are allergic to upadacitinib or any of the ingredients in RINVOQ. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.

What should I tell my HCP BEFORE starting RINVOQ?

Tell your HCP if you:

• Are being treated for an infection, have an infection that won't go away or keeps coming back, or have symptoms of an infection, such as:
  • - Fever, sweating, or chills
  • - Shortness of breath
  • - Warm, red, or painful skin or sores on your body
  • - Muscle aches
  • - Feeling tired
  • - Blood in phlegm
  • - Diarrhea or stomach pain
  • - Cough
  • - Weight loss
  • - Burning when urinating or urinating more often than normal

  Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. RINVOQ and other medicines may affect each other, causing side effects.

  Especially tell your HCP if you take:

  • Medicines for fungal or bacterial infections
  • Rifampicin or phenytoin
  • Medicines that affect your immune system

  If you are not sure if you are taking any of these medicines, ask your HCP or pharmacist.

  What should I avoid while taking RINVOQ?

  Avoid food or drink containing grapefruit during treatment with RINVOQ as it may increase the risk of side effects.

  What should I do or tell my HCP AFTER starting RINVOQ?

  • Tell your HCP right away if you have any symptoms of an infection. RINVOQ can make you more likely to get infections or make any infections you have worse.
  • Get emergency help right away if you have any symptoms of a heart attack or stroke while taking RINVOQ, including:
    • - Discomfort in the center of your chest that lasts for more than a few minutes or that goes away and comes back
    • - Severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw
    • - Pain or discomfort in your arms, back, neck, jaw, or stomach
    • - Shortness of breath with or without chest discomfort
    • - Breaking out in a cold sweat
    • - Nausea or vomiting
    • - Feeling lightheaded
    • - Weakness in one part or on one side of your body
    • - Slurred speech
    • - Swelling
    • - Pain or tenderness in one or both legs
    • - Sudden unexplained chest or upper back pain
    • - Shortness of breath or difficulty breathing

    What are other possible side effects of RINVOQ?

    Common side effects include upper respiratory tract infections (common cold, sinus infections), shingles (herpes zoster), herpes simplex virus infections (including cold sores), bronchitis, nausea, cough, fever, acne, headache, increased blood levels of creatine phosphokinase, allergic reactions, inflammation of hair follicles, stomach-area (abdominal) pain, increased weight, flu, tiredness, lower number of certain types of white blood cells (neutropenia, lymphopenia, leukopenia), muscle pain, flu-like illness, rash, increased blood cholesterol levels, increased liver enzyme levels, pneumonia, low number of red blood cells (anemia), and infection of the stomach and intestine (gastroenteritis).

    A separation or tear to the lining of the back part of the eye (retinal detachment) has happened in people with atopic dermatitis treated with RINVOQ. Call your HCP right away if you have any sudden changes in your vision during treatment with RINVOQ.

    Some people taking RINVOQ may see medicine residue (a whole tablet or tablet pieces) in their stool. If this happens, call your HCP.

    These are not all the possible side effects of RINVOQ.

    How should I take RINVOQ/RINVOQ LQ?

    RINVOQ is taken once a day with or without food. Do not split, crush, or chew the tablet. Take RINVOQ exactly as your HCP tells you to use it. RINVOQ is available in 15 mg, 30 mg, and 45 mg extended-release tablets. RINVOQ LQ is taken twice a day with or without food. RINVOQ LQ is available in a 1 mg/mL oral solution. RINVOQ LQ is not the same as RINVOQ tablets. Do not switch between RINVOQ LQ and RINVOQ tablets unless the change has been made by your HCP.

    **Unless otherwise stated, "RINVOQ" in the IMPORTANT SAFETY INFORMATION refers to RINVOQ and RINVOQ LQ.

    This is the most important information to know about RINVOQ. For more information, talk to your HCP.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

    RINVOQ is a prescription medicine used to treat:

    • Adults with moderate to severe rheumatoid arthritis(RA) when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used, and did not work well or could not be tolerated.
    • Adults with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
    • Adults with active ankylosing spondylitis (AS) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
    • Adults with active non-radiographic axial spondyloarthritis (nr-axSpA) with objective signs of inflammation when a TNF blocker medicine has been used, and did not work well or could not be tolerated.
    • Adults with moderate to severe ulcerative colitis (UC) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
    • Adults with moderate to severe Crohn's disease (CD) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.

    It is not known if RINVOQ is safe and effective in children with ankylosing spondylitis, non-radiographic axial spondyloarthritis, ulcerative colitis, or Crohn's disease.

    • Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis [AD]) that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections is not recommended.

    It is not known if RINVOQ is safe and effective in children under 12 years of age with atopic dermatitis.

    It is not known if RINVOQ LQ is safe and effective in children with atopic dermatitis.

    RINVOQ/RINVOQ LQ is a prescription medicine used to treat:

    • Children 2 years of age and older with active polyarticular juvenile idiopathic arthritis (pJIA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.
    • Children 2 to less than 18 years of age with active psoriatic arthritis (PsA) when 1 or more medicines called TNF blockers have been used, and did not work well or could not be tolerated.

    It is not known if RINVOQ/RINVOQ LQ is safe and effective in children under 2 years of age with polyarticular juvenile idiopathic arthritis or psoriatic arthritis.

    If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.

    Legal Notices. © 2024 AbbVie. All rights reserved. If you have any questions about AbbVie's RINVOQ.com website that have not been answered, click here. This website and the information contained herein is intended for use by US residents only, is provided for informational purposes only and is not intended to replace a discussion with a healthcare provider. All decisions regarding patient care must be made with a healthcare provider and consider the unique characteristics of each patient.